Sign in
4

Changes in Ownership

NEOGENOMICS INC Filed Acc 0001077183-19-000013

Director sold 18,889 shares at $18.90 ($357,002)

  • Director acquired 18,889 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

HIPP RAYMOND R · Director

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2019-02-26 Exercise or conversion : show line 1 in the form +10,000 $4.78 $47,800 297,580 D
2019-02-26 Exercise or conversion : show line 2 in the form +5,556 $9.11 $50,615 303,136 D
2019-02-26 Exercise or conversion : show line 3 in the form +3,333 $7.27 $24,231 306,469 D
2019-02-26 Sale : show line 4 in the form −18,889 $18.90 $357,002 287,580 D
Open-market sales · 18,889 sh · avg $18.90 · $357,002

Table II: Derivative

3 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2019-02-26 Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) −10,000 $4.78 2020-05-06 10,000 0 D
2019-02-26 Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) −5,556 $9.11 2021-07-28 5,556 2,777 D
2019-02-26 Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) −3,333 $7.27 2022-05-25 3,333 6,667 D
Loading xslF345X03/wf-form4_155139102644751.xml…